Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study

Andrew Jeremijenko, View ORCID ProfileHiam Chemaitelly, View ORCID ProfileHoussein H. Ayoub, Moza Abdellatif Hassan Abdulla, View ORCID ProfileAbdul-Badi Abou-Samra, Jameela Ali A.A. Al Ajmi, Nasser Ali Asad Al Ansari, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Ahmed Al-Mohammed, Naema Hassan Abdulla Al Molawi, Huda Mohamad Al Naomi, Adeel A. Butt, View ORCID ProfilePeter Coyle, Reham Awni El Kahlout, Imtiaz Gillani, Anvar Hassan Kaleeckal, Naseer Ahmad Masoodi, Anil George Thomas, Hanaa Nafady-Hego, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Nourah B M Younes, Hanan F. Abdul Rahim, Hadi M. Yassine, View ORCID ProfileMohamed G. Al Kuwari, Hamad Eid Al Romaihi, Sheikh Mohammad Al Thani, Roberto Bertollini, View ORCID ProfileLaith J. Abu-Raddad
doi: https://doi.org/10.1101/2020.09.24.20200543
Andrew Jeremijenko
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: AJeremijenko@hamad.qa lja2002@qatar-med.cornell.edu
Hiam Chemaitelly
2Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
3World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hiam Chemaitelly
Houssein H. Ayoub
4Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Houssein H. Ayoub
Moza Abdellatif Hassan Abdulla
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdul-Badi Abou-Samra
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Abdul-Badi Abou-Samra
Jameela Ali A.A. Al Ajmi
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nasser Ali Asad Al Ansari
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zaina Al Kanaani
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdullatif Al Khal
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Einas Al Kuwari
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed Al-Mohammed
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naema Hassan Abdulla Al Molawi
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huda Mohamad Al Naomi
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adeel A. Butt
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Coyle
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Coyle
Reham Awni El Kahlout
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Imtiaz Gillani
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anvar Hassan Kaleeckal
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naseer Ahmad Masoodi
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anil George Thomas
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanaa Nafady-Hego
1Hamad Medical Corporation, Doha, Qatar
5Microbiology and Immunology Department, Faculty of Medicine, Assiut University, Assiut, Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Nizar Latif
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Riyazuddin Mohammad Shaik
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nourah B M Younes
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanan F. Abdul Rahim
6College of Health Sciences, QU Health, Qatar University, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hadi M. Yassine
7Biomedical Research Center, Qatar University, Doha, Qatar
8Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed G. Al Kuwari
9Primary Health Care Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohamed G. Al Kuwari
Hamad Eid Al Romaihi
10Ministry of Public Health, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheikh Mohammad Al Thani
10Ministry of Public Health, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto Bertollini
10Ministry of Public Health, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laith J. Abu-Raddad
2Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
3World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
11Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laith J. Abu-Raddad
  • For correspondence: AJeremijenko@hamad.qa lja2002@qatar-med.cornell.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Qatar experienced a large severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic that disproportionately affected the craft and manual workers (CMWs) who constitute 60% of the population. This study aimed to investigate level of immunity in communities within this population as well as infection exposure required to achieve herd immunity.

Methods Anti-SARS-CoV-2 seropositivity was assessed in ten CMW communities between June 21 and September 9, 2020. PCR positivity, infection positivity (antibody and/or PCR positive), and infection severity rate were also estimated. Associations with anti-SARS-CoV-2 positivity were investigated using regression analyses.

Results Study included 4,970 CMWs who were mostly men (95.0%) and <40 years of age (71.5%). Seropositivity ranged from 54.9% (95% CI: 50.2-59.4%) to 83.8% (95% CI: 79.1-87.7%) in the different CMW communities. Pooled mean seropositivity across all communities was 66.1% (95% CI: 61.5-70.6%). PCR positivity ranged from 0.0% to 10.5% (95% CI: 7.4-14.8%) in the different CMW communities. Pooled mean PCR positivity was 3.9% (95% CI: 1.6-6.9%). Median cycle threshold (Ct) value was 34.0 (range: 15.8-37.4)—majority (79.5%) of PCR-positive individuals had Ct value >30 indicative of earlier rather than recent infection. Infection positivity (antibody and/or PCR positive) ranged from 62.5% (95% CI: 58.3-66.7%) to 83.8% (95% CI: 79.1-87.7%) in the different CMW communities. Pooled mean infection positivity was 69.5% (95% CI: 62.8-75.9%). Only five infections were ever severe and one was ever critical—an infection severity rate of 0.2% (95% CI: 0.1-0.4%).

Conclusions Based on an extended range of epidemiological measures, active infection is rare in these communities with limited if any sustainable infection transmission for clusters to occur. At least some CMW communities in Qatar have reached or nearly reached herd immunity for SARS-CoV-2 infection at a proportion of ever infection of 65-70%.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors are grateful for support provided by the Ministry of Public Health, Hamad Medical Corporation, and the Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core, both at Weill Cornell Medicine-Qatar. The statements made herein are solely the responsibility of the authors.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by Hamad Medical Corporation and Weill Cornell Medicine-Qatar Institutional Review Boards.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data are available in an aggregate form in the main text and supplementary materials.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 28, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study
Andrew Jeremijenko, Hiam Chemaitelly, Houssein H. Ayoub, Moza Abdellatif Hassan Abdulla, Abdul-Badi Abou-Samra, Jameela Ali A.A. Al Ajmi, Nasser Ali Asad Al Ansari, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Ahmed Al-Mohammed, Naema Hassan Abdulla Al Molawi, Huda Mohamad Al Naomi, Adeel A. Butt, Peter Coyle, Reham Awni El Kahlout, Imtiaz Gillani, Anvar Hassan Kaleeckal, Naseer Ahmad Masoodi, Anil George Thomas, Hanaa Nafady-Hego, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Nourah B M Younes, Hanan F. Abdul Rahim, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Sheikh Mohammad Al Thani, Roberto Bertollini, Laith J. Abu-Raddad
medRxiv 2020.09.24.20200543; doi: https://doi.org/10.1101/2020.09.24.20200543
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study
Andrew Jeremijenko, Hiam Chemaitelly, Houssein H. Ayoub, Moza Abdellatif Hassan Abdulla, Abdul-Badi Abou-Samra, Jameela Ali A.A. Al Ajmi, Nasser Ali Asad Al Ansari, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Ahmed Al-Mohammed, Naema Hassan Abdulla Al Molawi, Huda Mohamad Al Naomi, Adeel A. Butt, Peter Coyle, Reham Awni El Kahlout, Imtiaz Gillani, Anvar Hassan Kaleeckal, Naseer Ahmad Masoodi, Anil George Thomas, Hanaa Nafady-Hego, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Nourah B M Younes, Hanan F. Abdul Rahim, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Sheikh Mohammad Al Thani, Roberto Bertollini, Laith J. Abu-Raddad
medRxiv 2020.09.24.20200543; doi: https://doi.org/10.1101/2020.09.24.20200543

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (240)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1419)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (584)
  • Epidemiology (10295)
  • Forensic Medicine (6)
  • Gastroenterology (527)
  • Genetic and Genomic Medicine (2629)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1731)
  • Health Policy (789)
  • Health Systems and Quality Improvement (672)
  • Hematology (266)
  • HIV/AIDS (565)
  • Infectious Diseases (except HIV/AIDS) (12091)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (289)
  • Neurology (2461)
  • Nursing (145)
  • Nutrition (377)
  • Obstetrics and Gynecology (492)
  • Occupational and Environmental Health (568)
  • Oncology (1322)
  • Ophthalmology (401)
  • Orthopedics (146)
  • Otolaryngology (237)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (780)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2397)
  • Public and Global Health (5006)
  • Radiology and Imaging (893)
  • Rehabilitation Medicine and Physical Therapy (525)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (245)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)